The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature

Anti-Müllerian hormone (AMH) is an established marker of ovarian reserve and a good predictor of poor or excessive ovarian response after controlled hyperstimulation. However, it is unclear whether it can predict the ultimate outcome of assisted conception, live birth. We undertook a systematic revi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human reproduction update 2014-07, Vol.20 (4), p.560-570
Hauptverfasser: Iliodromiti, Stamatina, Kelsey, Thomas W, Wu, Olivia, Anderson, Richard A, Nelson, Scott M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 570
container_issue 4
container_start_page 560
container_title Human reproduction update
container_volume 20
creator Iliodromiti, Stamatina
Kelsey, Thomas W
Wu, Olivia
Anderson, Richard A
Nelson, Scott M
description Anti-Müllerian hormone (AMH) is an established marker of ovarian reserve and a good predictor of poor or excessive ovarian response after controlled hyperstimulation. However, it is unclear whether it can predict the ultimate outcome of assisted conception, live birth. We undertook a systematic review and meta-analysis to examine whether AMH is a predictor of live birth in women undergoing assisted conception. The study was conducted according to the PRISMA guidelines. PubMed, Embase, Medline, Web of Knowledge and the Cochrane trial register and unpublished literature were searched. Studies fulfilling the eligibility criteria were included in the systematic review and those with extractable data were included in the meta-analysis. Quality assessment was performed with the QUADAS 2 checklist. A summary estimate of diagnostic odds ratio (DOR) was derived using the random effects model for binary data. A hierarchical summary receiver operating characteristic model provided pooled estimates before and after adjusting for age and AMH assay as covariates. Out of 361 non-duplicate studies, 47 were selected; 17 met the eligibility criteria and 13 had extractable data and thus were included in the meta-analysis. Three out of the 13 studies included only women with expected low ovarian reserve and were analysed individually from the remaining 10 to minimize heterogeneity. The DOR for women with unknown ovarian reserve (n = 5764 women) was 2.39 (95% confidence interval (CI): 1.85-3.08). After adjustment for age the DOR was little changed at 2.48 (95% CI: 1.81-3.22) and the DOR adjusted for AMH assay was almost identical at 2.42 (95% CI: 1.86-3.14). For women with expected low ovarian reserve (n = 542 women) the DOR was 4.63 (95% CI: 2.75-7.81). AMH, independently of age, has some association with predicting live birth after assisted conception and may be helpful when counselling couples before undergoing fertility treatment. However, its predictive accuracy is poor.
doi_str_mv 10.1093/humupd/dmu003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1539474814</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1539474814</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-24de4e5395de0b365cc089e63e0b4258579c05cae43c86c5468f73e9407aa4223</originalsourceid><addsrcrecordid>eNo9kctOwzAQRS0EoqWwZIu8ZBPq-JEHO1TxkkBsyjqaOhPVKImD7RT1P_gcdvwYrgqsxmMdnxn5EnKesquUlWK-HrtxqOd1NzImDsg0lRlLuMjKw3gWSiUyL7IJOfH-jbE0S4v8mEy4VIJzzqbkc7lGOjisjQ5mgxS0Hh3oLbUNhT6Y5Pn7q23RGejp2rrO9kgb62i7g1fGhTWFJqCj4L3xAWuqba9xCMb21xSo38bLDoLR1OHG4Ee01rTDAAn00G7jo92oELdoTfRAGB2ekqMGWo9nv3VGXu9ul4uH5Onl_nFx85RoURYh4bJGiUqUqka2EpnSmhUlZiJ2kqtC5aVmSgNKoYtMK5kVTS6wlCwHkJyLGbncewdn30f0oeqM19i20KMdfZVGt8xlkcqIJntUO-u9w6YanOnAbauUVbsgqn0Q1T6IyF_8qsdVh_U__ffz4gdJoonW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1539474814</pqid></control><display><type>article</type><title>The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Iliodromiti, Stamatina ; Kelsey, Thomas W ; Wu, Olivia ; Anderson, Richard A ; Nelson, Scott M</creator><creatorcontrib>Iliodromiti, Stamatina ; Kelsey, Thomas W ; Wu, Olivia ; Anderson, Richard A ; Nelson, Scott M</creatorcontrib><description>Anti-Müllerian hormone (AMH) is an established marker of ovarian reserve and a good predictor of poor or excessive ovarian response after controlled hyperstimulation. However, it is unclear whether it can predict the ultimate outcome of assisted conception, live birth. We undertook a systematic review and meta-analysis to examine whether AMH is a predictor of live birth in women undergoing assisted conception. The study was conducted according to the PRISMA guidelines. PubMed, Embase, Medline, Web of Knowledge and the Cochrane trial register and unpublished literature were searched. Studies fulfilling the eligibility criteria were included in the systematic review and those with extractable data were included in the meta-analysis. Quality assessment was performed with the QUADAS 2 checklist. A summary estimate of diagnostic odds ratio (DOR) was derived using the random effects model for binary data. A hierarchical summary receiver operating characteristic model provided pooled estimates before and after adjusting for age and AMH assay as covariates. Out of 361 non-duplicate studies, 47 were selected; 17 met the eligibility criteria and 13 had extractable data and thus were included in the meta-analysis. Three out of the 13 studies included only women with expected low ovarian reserve and were analysed individually from the remaining 10 to minimize heterogeneity. The DOR for women with unknown ovarian reserve (n = 5764 women) was 2.39 (95% confidence interval (CI): 1.85-3.08). After adjustment for age the DOR was little changed at 2.48 (95% CI: 1.81-3.22) and the DOR adjusted for AMH assay was almost identical at 2.42 (95% CI: 1.86-3.14). For women with expected low ovarian reserve (n = 542 women) the DOR was 4.63 (95% CI: 2.75-7.81). AMH, independently of age, has some association with predicting live birth after assisted conception and may be helpful when counselling couples before undergoing fertility treatment. However, its predictive accuracy is poor.</description><identifier>ISSN: 1355-4786</identifier><identifier>EISSN: 1460-2369</identifier><identifier>DOI: 10.1093/humupd/dmu003</identifier><identifier>PMID: 24532220</identifier><language>eng</language><publisher>England</publisher><subject>Age Factors ; Anti-Mullerian Hormone - metabolism ; Biomarkers - metabolism ; Epidemiologic Methods ; Female ; Fertilization in Vitro ; Humans ; Live Birth ; Ovary - physiology</subject><ispartof>Human reproduction update, 2014-07, Vol.20 (4), p.560-570</ispartof><rights>The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-24de4e5395de0b365cc089e63e0b4258579c05cae43c86c5468f73e9407aa4223</citedby><cites>FETCH-LOGICAL-c398t-24de4e5395de0b365cc089e63e0b4258579c05cae43c86c5468f73e9407aa4223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24532220$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iliodromiti, Stamatina</creatorcontrib><creatorcontrib>Kelsey, Thomas W</creatorcontrib><creatorcontrib>Wu, Olivia</creatorcontrib><creatorcontrib>Anderson, Richard A</creatorcontrib><creatorcontrib>Nelson, Scott M</creatorcontrib><title>The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature</title><title>Human reproduction update</title><addtitle>Hum Reprod Update</addtitle><description>Anti-Müllerian hormone (AMH) is an established marker of ovarian reserve and a good predictor of poor or excessive ovarian response after controlled hyperstimulation. However, it is unclear whether it can predict the ultimate outcome of assisted conception, live birth. We undertook a systematic review and meta-analysis to examine whether AMH is a predictor of live birth in women undergoing assisted conception. The study was conducted according to the PRISMA guidelines. PubMed, Embase, Medline, Web of Knowledge and the Cochrane trial register and unpublished literature were searched. Studies fulfilling the eligibility criteria were included in the systematic review and those with extractable data were included in the meta-analysis. Quality assessment was performed with the QUADAS 2 checklist. A summary estimate of diagnostic odds ratio (DOR) was derived using the random effects model for binary data. A hierarchical summary receiver operating characteristic model provided pooled estimates before and after adjusting for age and AMH assay as covariates. Out of 361 non-duplicate studies, 47 were selected; 17 met the eligibility criteria and 13 had extractable data and thus were included in the meta-analysis. Three out of the 13 studies included only women with expected low ovarian reserve and were analysed individually from the remaining 10 to minimize heterogeneity. The DOR for women with unknown ovarian reserve (n = 5764 women) was 2.39 (95% confidence interval (CI): 1.85-3.08). After adjustment for age the DOR was little changed at 2.48 (95% CI: 1.81-3.22) and the DOR adjusted for AMH assay was almost identical at 2.42 (95% CI: 1.86-3.14). For women with expected low ovarian reserve (n = 542 women) the DOR was 4.63 (95% CI: 2.75-7.81). AMH, independently of age, has some association with predicting live birth after assisted conception and may be helpful when counselling couples before undergoing fertility treatment. However, its predictive accuracy is poor.</description><subject>Age Factors</subject><subject>Anti-Mullerian Hormone - metabolism</subject><subject>Biomarkers - metabolism</subject><subject>Epidemiologic Methods</subject><subject>Female</subject><subject>Fertilization in Vitro</subject><subject>Humans</subject><subject>Live Birth</subject><subject>Ovary - physiology</subject><issn>1355-4786</issn><issn>1460-2369</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kctOwzAQRS0EoqWwZIu8ZBPq-JEHO1TxkkBsyjqaOhPVKImD7RT1P_gcdvwYrgqsxmMdnxn5EnKesquUlWK-HrtxqOd1NzImDsg0lRlLuMjKw3gWSiUyL7IJOfH-jbE0S4v8mEy4VIJzzqbkc7lGOjisjQ5mgxS0Hh3oLbUNhT6Y5Pn7q23RGejp2rrO9kgb62i7g1fGhTWFJqCj4L3xAWuqba9xCMb21xSo38bLDoLR1OHG4Ee01rTDAAn00G7jo92oELdoTfRAGB2ekqMGWo9nv3VGXu9ul4uH5Onl_nFx85RoURYh4bJGiUqUqka2EpnSmhUlZiJ2kqtC5aVmSgNKoYtMK5kVTS6wlCwHkJyLGbncewdn30f0oeqM19i20KMdfZVGt8xlkcqIJntUO-u9w6YanOnAbauUVbsgqn0Q1T6IyF_8qsdVh_U__ffz4gdJoonW</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Iliodromiti, Stamatina</creator><creator>Kelsey, Thomas W</creator><creator>Wu, Olivia</creator><creator>Anderson, Richard A</creator><creator>Nelson, Scott M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140701</creationdate><title>The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature</title><author>Iliodromiti, Stamatina ; Kelsey, Thomas W ; Wu, Olivia ; Anderson, Richard A ; Nelson, Scott M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-24de4e5395de0b365cc089e63e0b4258579c05cae43c86c5468f73e9407aa4223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Age Factors</topic><topic>Anti-Mullerian Hormone - metabolism</topic><topic>Biomarkers - metabolism</topic><topic>Epidemiologic Methods</topic><topic>Female</topic><topic>Fertilization in Vitro</topic><topic>Humans</topic><topic>Live Birth</topic><topic>Ovary - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iliodromiti, Stamatina</creatorcontrib><creatorcontrib>Kelsey, Thomas W</creatorcontrib><creatorcontrib>Wu, Olivia</creatorcontrib><creatorcontrib>Anderson, Richard A</creatorcontrib><creatorcontrib>Nelson, Scott M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction update</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iliodromiti, Stamatina</au><au>Kelsey, Thomas W</au><au>Wu, Olivia</au><au>Anderson, Richard A</au><au>Nelson, Scott M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature</atitle><jtitle>Human reproduction update</jtitle><addtitle>Hum Reprod Update</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>20</volume><issue>4</issue><spage>560</spage><epage>570</epage><pages>560-570</pages><issn>1355-4786</issn><eissn>1460-2369</eissn><abstract>Anti-Müllerian hormone (AMH) is an established marker of ovarian reserve and a good predictor of poor or excessive ovarian response after controlled hyperstimulation. However, it is unclear whether it can predict the ultimate outcome of assisted conception, live birth. We undertook a systematic review and meta-analysis to examine whether AMH is a predictor of live birth in women undergoing assisted conception. The study was conducted according to the PRISMA guidelines. PubMed, Embase, Medline, Web of Knowledge and the Cochrane trial register and unpublished literature were searched. Studies fulfilling the eligibility criteria were included in the systematic review and those with extractable data were included in the meta-analysis. Quality assessment was performed with the QUADAS 2 checklist. A summary estimate of diagnostic odds ratio (DOR) was derived using the random effects model for binary data. A hierarchical summary receiver operating characteristic model provided pooled estimates before and after adjusting for age and AMH assay as covariates. Out of 361 non-duplicate studies, 47 were selected; 17 met the eligibility criteria and 13 had extractable data and thus were included in the meta-analysis. Three out of the 13 studies included only women with expected low ovarian reserve and were analysed individually from the remaining 10 to minimize heterogeneity. The DOR for women with unknown ovarian reserve (n = 5764 women) was 2.39 (95% confidence interval (CI): 1.85-3.08). After adjustment for age the DOR was little changed at 2.48 (95% CI: 1.81-3.22) and the DOR adjusted for AMH assay was almost identical at 2.42 (95% CI: 1.86-3.14). For women with expected low ovarian reserve (n = 542 women) the DOR was 4.63 (95% CI: 2.75-7.81). AMH, independently of age, has some association with predicting live birth after assisted conception and may be helpful when counselling couples before undergoing fertility treatment. However, its predictive accuracy is poor.</abstract><cop>England</cop><pmid>24532220</pmid><doi>10.1093/humupd/dmu003</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-4786
ispartof Human reproduction update, 2014-07, Vol.20 (4), p.560-570
issn 1355-4786
1460-2369
language eng
recordid cdi_proquest_miscellaneous_1539474814
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Age Factors
Anti-Mullerian Hormone - metabolism
Biomarkers - metabolism
Epidemiologic Methods
Female
Fertilization in Vitro
Humans
Live Birth
Ovary - physiology
title The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T04%3A12%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20predictive%20accuracy%20of%20anti-M%C3%BCllerian%20hormone%20for%20live%20birth%20after%20assisted%20conception:%20a%20systematic%20review%20and%20meta-analysis%20of%20the%20literature&rft.jtitle=Human%20reproduction%20update&rft.au=Iliodromiti,%20Stamatina&rft.date=2014-07-01&rft.volume=20&rft.issue=4&rft.spage=560&rft.epage=570&rft.pages=560-570&rft.issn=1355-4786&rft.eissn=1460-2369&rft_id=info:doi/10.1093/humupd/dmu003&rft_dat=%3Cproquest_cross%3E1539474814%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1539474814&rft_id=info:pmid/24532220&rfr_iscdi=true